Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity

Pathology

Volumn 40, Issue 5, 2008, Pages 481-486

  Mai, Kien T ^a   Kohler, Derek M ^b   Belanger, Eric C ^b   Robertson, Susan J ^b   Wang, Don ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NONE

Author keywords

Carcinoma; Clear cell; Cytokeratin 7; Kidney

Indexed keywords

CYTOKERATIN 7;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOPLASM; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; METASTASIS;

EID: 46749148102     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802197962     Document Type: Article

References (17)

1. rd Series, Fascicle 11. Washington, DC: Armed Forces Institute of Pathology, 1995; 92-136.
2. Rendon RA, Stanietzky N, Panzarella T, et al. The natural history of small renal masses. J Urol 2000; 164: 1143-7.
3. Salama ME, Guru K, Stricker H, et al. pT1 substaging in renal cell carcinoma: Validation of the 2002 TNM staging modification of malignant renal epithelial tumors. J Urol 2005; 173: 1492-5.
4. Kovacs G, Akhtar M, Beckwith BJ. The heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-3.
5. Kovacs G. Molecular differential pathology of renal tumours. Histopathology 1993; 22: 1-8.
6. Lau WK, Cheville JC, Blute ML, Weaver AL, Zincke H. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy. Urology 2002; 59: 532-7.
7. Remzi M, Ozsoy M, Klingler HC, et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 2006; 176: 896-9.
8. No authors listed. Renal histopathology in kidney transplant recipients immunosuppressed with cyclosporin A: results of an international workshop. Clin Nephrol 1985; 24: 107-19.
9. Mazal PR, Stichenwirth M, Koller A, Blach S, Haitel A, Susani M. Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study. Mod Pathol 2005; 18: 535-40.
10. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol 2002; 10: 332-8.
11. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 10: 537-44.
12. Yang XJ, Tan MH, Kim HL. A molecular classification of papillary renal cell carcinoma. Cancer Res 2005; 65: 5628-37.
13. Sim SJ, Ro JY, Ordonez NG, Park YW, Kee KH, Ayala AG. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study. Mod Pathol 1999; 12: 351-5.
14. Skinnider BF, Folpe AL, Hennigar RA, et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am J Surg Pathol 2005; 29: 747-54.
15. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol 2006; 30: 141-53.
16. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24: 203-10.
17. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody 'Renal Cell Carcinoma Marker'. Am J Surg Pathol 2001; 25: 1485-92.